WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009135927) SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/135927    International Application No.:    PCT/EP2009/055576
Publication Date: 12.11.2009 International Filing Date: 08.05.2009
IPC:
C07D 513/04 (2006.01), C07D 519/00 (2006.01), A61K 31/429 (2006.01), A61P 25/00 (2006.01)
Applicants: LABORATORIOS DEL DR. ESTEVE, S.A. [ES/ES]; Avda. Mare de Déu de Montserrat, 221 E-08041 Barcelona (ES) (For All Designated States Except US).
MAS PRIÓ, Josep [ES/ES]; (ES) (For US Only).
TORRENS JOVER, Antoni [ES/ES]; (ES) (For US Only)
Inventors: MAS PRIÓ, Josep; (ES).
TORRENS JOVER, Antoni; (ES)
Agent: BERNARDO NORIEGA, Francisco; ABG Patentes, S.L. Avenida de Burgos, 16D Edificio Euromor E-28036 Madrid (ES)
Priority Data:
08380144.9 09.05.2008 EP
Title (EN) SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS
(FR) DÉRIVÉS DE N-PHÉNYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE SUBSTITUÉS UTILISÉS COMME LIGANDS DE 5-HT6
Abstract: front page image
(EN)The invention relates to compounds having pharmacological activity towards the 5-HT6 receptor, and more particularly to some N-phenyl-2,3-dihydroimidazo[2,1- b]thiazole-5 -sulfonamide derivatives, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT6 is involved.
(FR)La présente invention concerne des composés présentant une activité pharmacologique par rapport au récepteur 5-HT6, plus particulièrement des dérivés de N-phényl-2,3-dihydroimidazo[2,1- b]thiazole-5-sulfonamide, ainsi que des procédés de préparation de tels composés, des compositions pharmaceutiques comprenant ces composés et leur utilisation pour traiter et/ou prévenir une maladie dans laquelle 5-HT6 est impliqué.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)